what's more, the share price will rise towards the mid year in anticipation of the result of the Rett study. The current lag would appear to be due to a general sell-off (even much-fancied ADO is down) and the interest in a number of other biotechs at present. Nowabouts would seem quite a good time to buy, particularly given the lack of day trader interest at present.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.66 |
Change
0.070(0.48%) |
Mkt cap ! $1.823B | |||
| Open | High | Low | Value | Volume |
| $14.36 | $14.68 | $14.25 | $1.942M | 134.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 236 | $14.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.67 | 208 | 4 |
View Market Depth
| Last trade - 14.11pm 16/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |